Team 2: Solid Tumor Immunology Group (STIG)

In STIG we focus on developing novel immunotherapeutic combination strategies to treat solid tumors and on unraveling the tumor immune microenvironment to gain deeper insights in tumor escape mechanisms. For novel cancer immunotherapy strategies, STIG has got a special interest in combining immune stimulation with inhibition of immune suppression and in activating the innate immune system as the first line of defense against tumors.
Key words of our research are cancer immunotherapy, combination therapy, innate immunity, immune checkpoints, stroma, danger signals and hypoxia.

Team Leader
Prof. Dr. Evelien Smits

Associated promotors (alphabetically)
Prof. dr. Annemie Bogaerts
Dr. Christophe Deben
Prof. dr. Filip Lardon
Prof. dr. Patrick Pauwels
Prof. dr. Marc Peeters
Prof. dr. Christian Rolfo
Prof. dr. Jan Van Meerbeeck
Prof. dr. Paul Van Schil
Prof. dr. An Wouters

Postdoctoral researchers
Dr. Christophe Deben
Dr. Julie Jacobs

PhD students
Jorrit De Waele
Tal Flieswasser
Laurie Freire Boullosa
Elly Marcq
Vasiliki Siozopoulou
Jonas Van Audenaerde
Jinthe Van Loenhout

ATP CORE
Hilde Lambrechts
Céline Merlin